HIV mutagenesis and the evolution of antiretroviral drug resistance (Q35046890)

6 August 2017

1 reference

title

HIV mutagenesis and the evolution of antiretroviral drug resistance (English)

1 reference

6 August 2017

main subject

anti-retroviral agent

0 references

1 reference

Louis M Mansky

1

1 reference

6 August 2017

publication date

1 December 2002

1 reference

6 August 2017

published in

Drug Resistance Updates

1 reference

6 August 2017

volume

5

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

219-223

1 reference

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Evolutionary implications of the frequent horizontal transfer of mismatch repair genes

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Mutation rates among RNA viruses

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

The rise and fall of mutator bacteria.

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Mutator bacteria as a risk factor in treatment of infectious diseases

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Quasispecies, error catastrophe, and the antiviral activity of ribavirin

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Homeologous recombination and mismatch repair during transformation in Streptococcus pneumoniae: saturation of the Hex mismatch repair system

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

The antiretrovirus drug 3'-azido-3'-deoxythymidine increases the retrovirus mutation rate

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Emergence of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 variants, viral sequence variation, and disease progression in patients receiving antiretroviral chemotherapy

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Clinical significance of drug resistance in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

High mutation frequencies among Escherichia coli and Salmonella pathogens

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Lethal mutagenesis of HIV with mutagenic nucleoside analogs

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Combination of a Drug Targeting the Cell with a Drug Targeting the Virus Controls Human Immunodeficiency Virus Type 1 Resistance

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Activity of quinolones in the Ames Salmonella TA102 mutagenicity test and other bacterial genotoxicity assays

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Forward mutation rate of human immunodeficiency virus type 1 in a T lymphoid cell line

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

3'-Azido-3'-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Interaction of human immunodeficiency virus type 1 Vpr with the HHR23A DNA repair protein does not correlate with multiple biological functions of Vpr.

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Combination of drugs and drug-resistant reverse transcriptase results in a multiplicative increase of human immunodeficiency virus type 1 mutant frequencies

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Mutation frequencies and antibiotic resistance

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools.

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Very low cefotaxime concentrations select for hypermutable Streptococcus pneumoniae populations

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Use of mutator strains for characterization of novel antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Mutator natural Escherichia coli isolates have an unusual virulence phenotype.

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Incidence and impact of resistance against approved antiretroviral drugs

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Mismatch repair genes of Streptococcus pneumoniae: HexA confers a mutator phenotype in Escherichia coli by negative complementation

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Enzymes of evolutionary change

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Interactions between deoxyribonucleotide and DNA synthesis

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

1 reference

7 January 2021

Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Evolution of high mutation rates in experimental populations of E. coli

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Second-order selection in bacterial evolution: selection acting on mutation and recombination rates in the course of adaptation

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Evolution of digital organisms at high mutation rates leads to survival of the flattest

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia

1 reference

https://api.crossref.org/works/10.1016/S1368-7646(02)00118-8

7 January 2021

10.1016/S1368-7646(02)00118-8

Identifiers

DOI

1 reference

6 August 2017

1 reference